====== Oragenics ======

{{ :pharmaceutical_companies:oragenics.png?200|}}

===== Affiliations =====

==== Acquisitions ====

In May 2020, Oragenics acquired [[Noachis Terra]] to "develop and commercialize TerraCoV2, a vaccine candidate which could provide specific immunity from the novel coronavirus ([[:SARS-CoV-2]]).((Abraham, J. (2020, May 4). //Oragenics Acquires Noachis Terra Inc., To Develop Its TerraCoV2 NIH-Generated SARS-CoV-2 (COVID 19) Vaccine Candidate Utilizing “Spike Protein”.// Oragenics. https://archive.ph/U2x2L))

===== COVID-19 =====

Oragenics is developing an intranasal [[:COVID-19]] [[:vaccine]] product with [[BioDextris]].((Sullivan, M., & Golodetz, K. (2021, March 9). //Oragenics Enters into Material Transfer Agreement with Biodextris for Mucosal Adjuvant for Intranasal COVID-19 Vaccine.// Business Wire; Berkshire Hathaway. https://archive.ph/QrWCj))

In December 2021, the company extended its licensing and collaboration agreement with the [[:National Research Council of Canada]] that "will enable Oragenics to pursue an intranasal vaccine designed to protect against the SARS-CoV-2 Omicron variant."((Sullivan, M. (2021, December 20). //Oragenics Extends Collaboration with the National Research Council of Canada to Develop Vaccine against the Omicron Variant.// Oragenics. https://archive.ph/Q0nNC))

===== External links =====

  * [[https://wiki.whiteroseintelligence.com/en/Oragenics|White Rose Wiki]]